The Asia Pacific Thyroid Ablation Devices Market should witness market growth of 13.5% CAGR during the forecast period (2022-2028).
An endocrine surgeon uses the minimally invasive radiofrequency ablation (RFA) procedure under the supervision of ultrasound imaging. As the body processes the ablated tissue, the doctor uses targeted radio waves to disrupt the nodule's cells, forcing them to contract. Additionally, RFA helps patients quickly return to their regular daily activities. While the portion of the thyroid may be removed during surgery, RFA preserves thyroid integrity, supporting enhanced thyroid function.
Microwave ablation (MWA) has most recently been suggested as a treatment for thyroid nodules based on its use in other organs, particularly the liver, kidney, and lung.Furthermore, laser ablation therapy is a relatively recent non-surgical treatment option for benign thyroid nodules. The technique has been applied in the past to treat thyroid cysts and remove lymph nodes affected by thyroid cancer. Therefore, treatment for thyroid nodules using laser ablation therapy (LAT) is very much an outpatient treatment. Additionally, the innovative ablation procedure known as high-intensity focused ultrasound (HIFU) can effectively decrease thyroid nodules and relieve pressure-related symptoms.
The High-Income part ofthe Asia Pacific region experienced the greatest DALY rate for thyroid cancer in 2019 as well as the highest thyroid cancer-related mortality rates. Compared to other Asian regions, thisregion experienced substantially higher growth in DALYs. The rates of incidence, prevalence, mortality, and DALYofthyroid cancer in womenwere significantly higher than those in menthroughout all of Asia and in the High-Income Asia Pacific region. Men aged 80-89 years had a greater DALY rate than women among Asian thyroid cancer patients. Age-related increases in the DALY rate were slow, andage-related declines in thyroid cancer patient death were observed in the region. The age group from 40 to 79 years old had the highest frequency. Consequently, the demand for ablation devices is high in this region, which is beneficial for the market.
The China market dominated the Asia Pacific Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $22,799.6 Thousands by 2028. The Japan market is estimated to grow a CAGR of 12.8% during (2022-2028). Additionally, The India market would experience a CAGR of 14.2% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
An endocrine surgeon uses the minimally invasive radiofrequency ablation (RFA) procedure under the supervision of ultrasound imaging. As the body processes the ablated tissue, the doctor uses targeted radio waves to disrupt the nodule's cells, forcing them to contract. Additionally, RFA helps patients quickly return to their regular daily activities. While the portion of the thyroid may be removed during surgery, RFA preserves thyroid integrity, supporting enhanced thyroid function.
Microwave ablation (MWA) has most recently been suggested as a treatment for thyroid nodules based on its use in other organs, particularly the liver, kidney, and lung.Furthermore, laser ablation therapy is a relatively recent non-surgical treatment option for benign thyroid nodules. The technique has been applied in the past to treat thyroid cysts and remove lymph nodes affected by thyroid cancer. Therefore, treatment for thyroid nodules using laser ablation therapy (LAT) is very much an outpatient treatment. Additionally, the innovative ablation procedure known as high-intensity focused ultrasound (HIFU) can effectively decrease thyroid nodules and relieve pressure-related symptoms.
The High-Income part ofthe Asia Pacific region experienced the greatest DALY rate for thyroid cancer in 2019 as well as the highest thyroid cancer-related mortality rates. Compared to other Asian regions, thisregion experienced substantially higher growth in DALYs. The rates of incidence, prevalence, mortality, and DALYofthyroid cancer in womenwere significantly higher than those in menthroughout all of Asia and in the High-Income Asia Pacific region. Men aged 80-89 years had a greater DALY rate than women among Asian thyroid cancer patients. Age-related increases in the DALY rate were slow, andage-related declines in thyroid cancer patient death were observed in the region. The age group from 40 to 79 years old had the highest frequency. Consequently, the demand for ablation devices is high in this region, which is beneficial for the market.
The China market dominated the Asia Pacific Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $22,799.6 Thousands by 2028. The Japan market is estimated to grow a CAGR of 12.8% during (2022-2028). Additionally, The India market would experience a CAGR of 14.2% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Scope of the Study
By End-use
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Specialty Centers
- Others
By Type
- Radiofrequency Ablation
- Microwave Ablation
- Others
By Application
- Thyroid Cancer
- Thyroid Nodules
By Product
- Thermal-based Devices
- Non-thermal-based Devices
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Thyroid Ablation Devices Market, by End-use
1.4.2 Asia Pacific Thyroid Ablation Devices Market, by Type
1.4.3 Asia Pacific Thyroid Ablation Devices Market, by Application
1.4.4 Asia Pacific Thyroid Ablation Devices Market, by Product
1.4.5 Asia Pacific Thyroid Ablation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Thyroid Ablation Devices Market by End-use
3.1 Asia Pacific Hospitals Market by Country
3.2 Asia Pacific Ambulatory Surgical Centers (ASCs) Market by Country
3.3 Asia Pacific Cancer Specialty Centers Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Thyroid Ablation Devices Market by Type
4.1 Asia Pacific Radiofrequency Ablation Market by Country
4.2 Asia Pacific Microwave Ablation Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Thyroid Ablation Devices Market by Application
5.1 Asia Pacific Thyroid Cancer Market by Country
5.2 Asia Pacific Thyroid Nodules Market by Country
Chapter 6. Asia Pacific Thyroid Ablation Devices Market by Product
6.1 Asia Pacific Thermal-based Devices Market by Country
6.2 Asia Pacific Non-thermal-based Devices Market by Country
Chapter 7. Asia Pacific Thyroid Ablation Devices Market by Country
7.1 China Thyroid Ablation Devices Market
7.1.1 China Thyroid Ablation Devices Market by End-use
7.1.2 China Thyroid Ablation Devices Market by Type
7.1.3 China Thyroid Ablation Devices Market by Application
7.1.4 China Thyroid Ablation Devices Market by Product
7.2 Japan Thyroid Ablation Devices Market
7.2.1 Japan Thyroid Ablation Devices Market by End-use
7.2.2 Japan Thyroid Ablation Devices Market by Type
7.2.3 Japan Thyroid Ablation Devices Market by Application
7.2.4 Japan Thyroid Ablation Devices Market by Product
7.3 India Thyroid Ablation Devices Market
7.3.1 India Thyroid Ablation Devices Market by End-use
7.3.2 India Thyroid Ablation Devices Market by Type
7.3.3 India Thyroid Ablation Devices Market by Application
7.3.4 India Thyroid Ablation Devices Market by Product
7.4 South Korea Thyroid Ablation Devices Market
7.4.1 South Korea Thyroid Ablation Devices Market by End-use
7.4.2 South Korea Thyroid Ablation Devices Market by Type
7.4.3 South Korea Thyroid Ablation Devices Market by Application
7.4.4 South Korea Thyroid Ablation Devices Market by Product
7.5 Singapore Thyroid Ablation Devices Market
7.5.1 Singapore Thyroid Ablation Devices Market by End-use
7.5.2 Singapore Thyroid Ablation Devices Market by Type
7.5.3 Singapore Thyroid Ablation Devices Market by Application
7.5.4 Singapore Thyroid Ablation Devices Market by Product
7.6 Malaysia Thyroid Ablation Devices Market
7.6.1 Malaysia Thyroid Ablation Devices Market by End-use
7.6.2 Malaysia Thyroid Ablation Devices Market by Type
7.6.3 Malaysia Thyroid Ablation Devices Market by Application
7.6.4 Malaysia Thyroid Ablation Devices Market by Product
7.7 Rest of Asia Pacific Thyroid Ablation Devices Market
7.7.1 Rest of Asia Pacific Thyroid Ablation Devices Market by End-use
7.7.2 Rest of Asia Pacific Thyroid Ablation Devices Market by Type
7.7.3 Rest of Asia Pacific Thyroid Ablation Devices Market by Application
7.7.4 Rest of Asia Pacific Thyroid Ablation Devices Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Johnson & Johnson
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental &Regional Analysis
8.4.4 Research & Development Expenses
8.5 Theraclion SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Olympus Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Regional Analysis
8.8 BVM Medical Limited
8.8.1 Company Overview
8.9 MedWaves, Inc.
8.9.1 Company Overview
8.10. STARmed Co. Ltd.
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Methodology
LOADING...
